Literature DB >> 29924378

The atherogenic index of plasma and its impact on recanalization of chronic total occlusion.

Jan-Erik Guelker1, Alexander Bufe2, Christian Blockhaus2, Knut Kroeger2, Thomas Rock2, Ibrahim Akin3, Michael Behnes3, Kambis Mashayekhi4.   

Abstract

BACKGROUND: The plasma-derived atherogenic index (AIP) is associated with an increasing risk for cardiovascular diseases. Whether an increased AIP may predict the complexity of percutaneous coronary intervention (PCI) of chronic total occlusion (CTO), according to available research, has never been investigated before.
METHODS: Three hundred seventeen patients were included prospectively and treated with PCI for at least one CTO between 2012 and 2017. High-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) plasma levels were measured 24 h before PCI. All patients were stratified into tertiles of AIP (defined as 0.11, 0.11-0.21, > 0.21) based on their TG/HDL-C (AIP) levels.
RESULTS: Mean AIP of all patients undergoing CTO-PCI was 0.53 ± 0.29. The majority of patients were male (82.6%), and mean age was 61 ± 10.4 years. Increased AIP > 0.21 was associated with longer occlusion length (statistical trend p = 0.082) and stent routes (p = 0.022) and with a higher number of implanted stents (n > 4) (statistical trend p = 0.072). Success rates were similar in all AIP categories (p = 0.461). In-hospital PCI-related complications were rare and not statistically different (p = 0.852).
CONCLUSIONS: This study demonstrates for the first time that an increased AIP may predict the complexity of CTO-PCI and additionally may help to improve planning and quality of CTO-PCI.

Entities:  

Keywords:  atherogenic index; chronic total occlusion; coronary artery disease; percutaneous coronary intervention

Year:  2018        PMID: 29924378      PMCID: PMC8079089          DOI: 10.5603/CJ.a2018.0064

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  19 in total

1.  Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

Authors:  Tracey McLaughlin; Gerald Reaven; Fahim Abbasi; Cindy Lamendola; Mohammed Saad; David Waters; Joel Simon; Ronald M Krauss
Journal:  Am J Cardiol       Date:  2005-08-01       Impact factor: 2.778

2.  Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool.

Authors:  Yoshihiro Morino; Mitsuru Abe; Takeshi Morimoto; Takeshi Kimura; Yasuhiko Hayashi; Toshiya Muramatsu; Masahiko Ochiai; Yuichi Noguchi; Kenichi Kato; Yoshisato Shibata; Yoshikazu Hiasa; Osamu Doi; Takehiro Yamashita; Tomoaki Hinohara; Hiroyuki Tanaka; Kazuaki Mitsudo
Journal:  JACC Cardiovasc Interv       Date:  2011-02       Impact factor: 11.195

3.  Impact of body mass index on long-term mortality in women and men undergoing percutaneous coronary intervention for chronic total occlusion.

Authors:  Barbara E Stähli; Cathérine Gebhard; Michael Gick; Colmsee Herman; Miroslaw Ferenc; Kambis Mashayekhi; Heinz Joachim Buettner; Aurel Toma
Journal:  Int J Cardiol       Date:  2016-09-16       Impact factor: 4.164

4.  Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions.

Authors:  Salvatore D Tomasello; Marouane Boukhris; Simona Giubilato; Francesco Marzà; Roberto Garbo; Gaetano Contegiacomo; Antonio Marzocchi; Giampaolo Niccoli; Andrea Gagnor; Ferdinando Varbella; Alessandro Desideri; Paolo Rubartelli; Angelo Cioppa; Giorgio Baralis; Alfredo R Galassi
Journal:  Eur Heart J       Date:  2015-09-02       Impact factor: 29.983

5.  Evaluation of association between atherogenic index of plasma and intima-media thickness of the carotid artery for subclinic atherosclerosis in patients on maintenance hemodialysis.

Authors:  Gürsel Yildiz; Alptekin Duman; Hüseyin Aydin; Abdulkerim Yilmaz; Ender Hür; Kemal Mağden; Gülay Cetin; Ferhan Candan
Journal:  Hemodial Int       Date:  2013-04-01       Impact factor: 1.812

6.  log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.

Authors:  Michel P Hermans; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2010-12-14       Impact factor: 9.951

7.  The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.

Authors:  Ke Wan; Jianxun Zhao; Hao Huang; Qing Zhang; Xi Chen; Zhi Zeng; Li Zhang; Yucheng Chen
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

8.  Gender-and lesion number-dependent difference in "atherogenic index of plasma" in Chinese people with coronary heart disease.

Authors:  Wei Ni; Zhenyu Zhou; Tao Liu; Haoyu Wang; Jianping Deng; Xiaoyan Liu; Guoqiang Xing
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

9.  The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females.

Authors:  Michel P Hermans; Sylvie A Ahn; Michel F Rousseau
Journal:  Lipids Health Dis       Date:  2012-10-09       Impact factor: 3.876

10.  Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease.

Authors:  Shabnam Niroumand; Mohammad Khajedaluee; Majid Khadem-Rezaiyan; Maryam Abrishami; Mohammadreza Juya; Gholamhasan Khodaee; Maliheh Dadgarmoghaddam
Journal:  Med J Islam Repub Iran       Date:  2015-07-25
View more
  2 in total

1.  Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography.

Authors:  Tong Liu; Jinghua Liu; Zheng Wu; Yun Lv; Wenzheng Li
Journal:  Clin Cardiol       Date:  2021-03-09       Impact factor: 2.882

2.  Correlation between atherogenic index of plasma and coronary artery disease in males of different ages: a retrospective study.

Authors:  Lei Hong; Yu Han; Chunfeng Deng; Aihua Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-10-09       Impact factor: 2.174

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.